These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 5675882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response of the midpregnant human uterus to systemic administration of 15(S)-15-methyl-prostaglandin F2alpha.
    Toppozada M, Béguin F, Bygdeman M, Wiqvist N.
    Prostaglandins; 1972 Oct; 2(4):239-49. PubMed ID: 4666626
    [Abstract] [Full Text] [Related]

  • 4. The effect of the prostaglandin F compounds on the contractility of the pregnant human uterus.
    Bygdeman M, Kwon SU, Mukherjee T, Roth-Brandel U, Wiqvist N.
    Am J Obstet Gynecol; 1970 Feb 15; 106(4):567-72. PubMed ID: 5412850
    [Abstract] [Full Text] [Related]

  • 5. Induction of abortion by extra-ammiotic prostaglandin administration.
    Wiqvist N, Béguin F, Bygdeman M, Fernström I, Toppozada M.
    Prostaglandins; 1972 Jan 15; 1(1):37-53. PubMed ID: 4660224
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and acceptability of 15(S)-15-methyl-prostaglandin E2-methyl ester for midtrimester pregnancy termination.
    Bieniarz J, Hunter G, Scommegna A.
    Am J Obstet Gynecol; 1974 Nov 15; 120(6):840-3. PubMed ID: 4429095
    [Abstract] [Full Text] [Related]

  • 8. The induction of abortion by prostaglandin F 2 .
    Kinoshita K, Wagatsuma T, Hogaki M, Sakamoto S.
    Am J Obstet Gynecol; 1971 Nov 15; 111(6):855-7. PubMed ID: 5166392
    [Abstract] [Full Text] [Related]

  • 9. The use of an "unnatural" prostaglandin in the termination of pregnancy.
    Gillespie A, Beazley JM, van Dorp DA.
    J Obstet Gynaecol Br Commonw; 1971 Apr 15; 78(4):301-4. PubMed ID: 5558313
    [Abstract] [Full Text] [Related]

  • 10. Interaction of E prostaglandins and syntocinon on the pregnant human myometrium.
    Brummer HC.
    J Obstet Gynaecol Br Commonw; 1971 Apr 15; 78(4):305-9. PubMed ID: 5558314
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of prostaglandin induced uterine activity in the second trimester of pregnancy by beta-mimetic adrenergic agents.
    Lindmark G, Melander S, Nilsson BA, Zador G.
    Prostaglandins; 1973 Apr 15; 3(4):481-9. PubMed ID: 4147100
    [Abstract] [Full Text] [Related]

  • 12. Second trimester abortion with single intra-amniotic injection of prostaglandins E2 or F2 alpha.
    Karim SM, Sharma SD.
    Lancet; 1971 Jul 03; 2(7714):47-8. PubMed ID: 4103691
    [Abstract] [Full Text] [Related]

  • 13. In vivo inhibition of the human non-pregnant uterus by prostaglandin E2.
    Toppozada M, Gaafar A, Shaala S.
    Prostaglandins; 1974 Dec 10; 8(5):401-10. PubMed ID: 4453624
    [No Abstract] [Full Text] [Related]

  • 14. Letter: Intravenous prostaglandins and oxytocin for mid-trimester abortion.
    Coltart TM, Coe MJ.
    Lancet; 1975 Jan 18; 1(7899):173-4. PubMed ID: 46097
    [Abstract] [Full Text] [Related]

  • 15. The prospects of PGs in postconceptional therapy.
    Csapo AI.
    Prostaglandins; 1973 Mar 18; 3(3):245-89. PubMed ID: 4580931
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prostaglandin-oxytocin enhancement.
    Seppälä M, Vara P.
    Br Med J; 1972 Mar 18; 1(5802):747. PubMed ID: 5015335
    [Abstract] [Full Text] [Related]

  • 18. Induction of abortion by intra- and extra-amniotic prostaglandin F2 administration.
    Järvinen PA, Pennanen S, Ylöstalo P.
    Prostaglandins; 1973 Apr 18; 3(4):491-504. PubMed ID: 4729587
    [Abstract] [Full Text] [Related]

  • 19. Effects of oral administration of prostaglandins E 2 and F 2- on the human uterus.
    Karim SM.
    J Obstet Gynaecol Br Commonw; 1971 Apr 18; 78(4):289-93. PubMed ID: 5558311
    [No Abstract] [Full Text] [Related]

  • 20. The efficacy and acceptability of intravenously administered prostaglandin F as an abortifacient.
    Csapo AI, Sauvage JP, Wiest WG.
    Am J Obstet Gynecol; 1971 Dec 15; 111(8):1059-63. PubMed ID: 5129560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.